The Glucose Monitoring global market is expected to grow at single digit CAGR to reach $12,897.0 million by 2025

Monday, August 26, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Glucose Monitoring consists of products that are essential for patients suffering from diabetes.

NEW YORK, Aug. 26, 2019 /PRNewswire/ -- Read the full report:


the projected rise in the aged population and awareness about such conditions, the market is focused on growing with newer technology and improved products. According to IQ4I analysis, the Glucose Monitoring global market is expected to grow at single digit CAGR to reach $12,897.0 million by 2025. Factors driving the Glucose Monitoring market are a global rise in the prevalence and incidence of diabetes, continuous technological advancement, increasing demand for less invasive products, and an increase in R&D investments are driving the market growth. Increase in obesity population due to lifestyle changes, increase in urbanization, untapped markets like the Middle East, Africa shows that glucose monitoring market has vast opportunities in the coming years. Frequent product recalls i.e. glucose testing strips due to manufacturing defects or supply of expired test strips and less product differentiation among the self blood glucose monitors are the factors that are restraining the market growth. The limited reimbursement facilities and alternative treatments that include cell-based assays, biomarkers identification and artificial pancreas and high cost associated with Continuous Glucose Monitoring (CGM) are threats for the market growth.

Glucose Monitoring global market is classified based on products, sample type, end-users and geography. The products segment is divided into three segments i.e., Invasive, Non-Invasive and lab-based glucose monitoring products. The Invasive glucose monitoring products segment accounted the largest share in 2018 and is projected to grow at a low single digit CAGR from 2018 to 2025 due to technological advancements, easy use, patient-friendly, etc. Invasive products are classified into Self glucose monitoring and continuous glucose products. The self glucose monitoring segment accounted for the largest share in 2018 due to the development of minimally invasive products. The Self glucose monitoring products are further classified into blood glucose monitors, blood glucose test strips, lancets and others. The blood glucose testing strips segment accounted for the largest share in 2018 due development of no coding strips. The continuous glucose monitoring market includes sensors/receiver and transmitter. The continuous glucose market includes products sensors/receiver and transmitter. Continuous glucose segment is the fastest growing segment and is projected to grow at a strong double digit CAGR from 2018 to 2025.

Based on sample type the market is segmented into blood, urine and others. The blood segment accounted for the largest share in 2018 due to the accuracy of results. Other source based glucose monitoring segment is fastest growing segment and is projected to grow exponentially from 2018 to 2025 due to increases R&D investment, many products is CE approved and expected launch very soon in the market.

Based on end users the market is segmented into hospitals, private clinics, home care and ambulatory settings. Among end-users, home care segment accounted for the largest share in 2018 and is projected to grow at a low single digit CAGR from 2018 to 2025 due to the availability of over the counter (OTC) self blood glucose monitor and ease in operating these monitors and thereby reducing the frequent visits to hospitals or clinics for checking glucose levels.

Based on geography the market is segmented into North America (U.S. and Rest of North America), Europe (Germany, France, Italy and Others), Asia-Pacific (Japan, China, India and Others) and Rest of the World (Brazil, Middle East & others and Rest of Latin America). North America accounts for the highest market share followed by Europe. The steep rise in aging population, advancement in technology, awareness of people about treatment options and favorable government policies are driving factors of glucose monitoring market. However, Asian countries especially India and China are the fastest growing regions with its growing demand for glucose monitoring products.

Major players in Glucose monitoring market include Abbott Laboratories (U.S.), Roche (Switzerland), LifeScan (U.S.), Dexcom (U.S.), Medtronic, Inc. (Ireland), Ascensia (Switzerland), Arkray (Japan), Sinocare (China), B. Braun Melsungen AG (Germany), Bio-Rad (U.S.), etc.

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:North Americao U.S.o Others

Europeo Germanyo Italyo Franceo Others

Asia-Pacifico Japano Chinao Indiao Others

• Rest of the World (RoW)o Brazilo Rest of Latin Americao Middle-East (Middle East & Others)

Read the full report:

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________ Contact Clare: US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:

SOURCE Reportlinker

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store